PL353968A1 - Kompozycja do zapładniania in vitroKompozycja do zapładniania in vitro - Google Patents

Kompozycja do zapładniania in vitroKompozycja do zapładniania in vitro

Info

Publication number
PL353968A1
PL353968A1 PL00353968A PL35396800A PL353968A1 PL 353968 A1 PL353968 A1 PL 353968A1 PL 00353968 A PL00353968 A PL 00353968A PL 35396800 A PL35396800 A PL 35396800A PL 353968 A1 PL353968 A1 PL 353968A1
Authority
PL
Poland
Prior art keywords
ivf
composition
phosperglycid
protein
prepared
Prior art date
Application number
PL00353968A
Other languages
English (en)
Other versions
PL202224B1 (pl
Inventor
Tina MeinertzAndersen Tina Meinertz Andersen
Original Assignee
Novo Nordisk A/Snovo Nordisk A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk A/Snovo Nordisk A/S filed Critical Novo Nordisk A/Snovo Nordisk A/S
Publication of PL353968A1 publication Critical patent/PL353968A1/pl
Publication of PL202224B1 publication Critical patent/PL202224B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/81—Packaged device or kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
PL353968A 1999-09-16 2000-09-11 Stała kompozycja farmaceutyczna zawierająca związek HSA PL202224B1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA199901308 1999-09-16
PCT/DK2000/000500 WO2001019354A2 (en) 1999-09-16 2000-09-11 Composition for ivf

Publications (2)

Publication Number Publication Date
PL353968A1 true PL353968A1 (pl) 2003-12-15
PL202224B1 PL202224B1 (pl) 2009-06-30

Family

ID=8103409

Family Applications (1)

Application Number Title Priority Date Filing Date
PL353968A PL202224B1 (pl) 1999-09-16 2000-09-11 Stała kompozycja farmaceutyczna zawierająca związek HSA

Country Status (21)

Country Link
US (1) US6844313B1 (pl)
EP (1) EP1216059B1 (pl)
JP (1) JP2003509365A (pl)
KR (1) KR100757909B1 (pl)
CN (1) CN1222319C (pl)
AT (1) ATE306942T1 (pl)
AU (1) AU781994B2 (pl)
BR (1) BR0014058A (pl)
CA (1) CA2382908A1 (pl)
CZ (1) CZ2002591A3 (pl)
DE (1) DE60023324T2 (pl)
ES (1) ES2252048T3 (pl)
HU (1) HUP0202630A3 (pl)
IL (1) IL148234A0 (pl)
MX (1) MXPA02002439A (pl)
NO (1) NO323694B1 (pl)
PL (1) PL202224B1 (pl)
RU (1) RU2263516C2 (pl)
UA (1) UA78183C2 (pl)
WO (1) WO2001019354A2 (pl)
ZA (1) ZA200201383B (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ20012671A3 (cs) * 1999-02-26 2002-01-16 Novo Nordisk A/S Způsob in vitro oplodnění s pouľitím kultivačního média obsahujícího sterol aktivující meiosu
CA2382908A1 (en) 1999-09-16 2001-03-22 Novo Nordisk A/S Composition for ivf
MXPA02007818A (es) * 2000-02-25 2002-10-23 Schering Ag Tasa de implantacion mejorada utilizando ff-mas.
US6988613B2 (en) 2001-02-06 2006-01-24 Novo Nordisk A/S Composition for IVF
EP1245572A1 (en) 2001-03-26 2002-10-02 Schering Aktiengesellschaft Aminosterol compounds, their use in the preparation of meiosis-regulating medicaments and method for their preparation

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4175074A (en) 1976-08-23 1979-11-20 Deshmukh Arvind D Serum-soluble cholesterol compounds and method for their preparation
US4751219A (en) 1985-02-05 1988-06-14 Nederlandse Centrale Organisatie Voor Toegepast-Natuur-Wetenschappelijk Onderzoek Synthetic glycolipides, a process for the preparation thereof and several uses for these synthetic glycolipides
WO1990003429A1 (en) * 1988-09-23 1990-04-05 Cetus Corporation Lipid microemulsions for culture media
DE4221880A1 (de) 1992-07-03 1994-01-05 Alfatec Pharma Gmbh Feste und flüssige Lösungen von schwer wasserlöslichen Arzneistoffen
CA2150803C (en) * 1992-12-02 2006-01-31 Henry Auer Controlled release growth hormone containing microspheres
US5716777A (en) * 1994-06-23 1998-02-10 Novo Nordisk A/S Regulation of meiosis using sterols
US6281015B1 (en) * 1994-12-16 2001-08-28 Children's Medical Center Corp. Localized delivery of factors enhancing survival of transplanted cells
HUP9800731A3 (en) * 1995-03-06 2000-03-28 Novo Nordisk As Stimulation of meiosis
CA2224866A1 (en) 1995-06-23 1997-01-09 Novo Nordisk A/S Meiosis regulating compounds
GB9625175D0 (en) * 1996-12-04 1997-01-22 Medi Cult As Serum-free cell culture media
JP2001506656A (ja) * 1996-12-20 2001-05-22 ノボ ノルディスク アクティーゼルスカブ 減数分裂調節化合物
TR199902873T2 (xx) 1997-06-04 2000-04-21 Akzo Nobel N.V. Miyozun mod�lasyonu i�in 17�-aliloksi(tiyo)alkil-androstan t�revleri.
HUP9701554D0 (en) 1997-09-18 1997-11-28 Human Oltoanyagtermeloe Gyogys Pharmaceutical composition containing plazma proteins
EP1098652A2 (en) 1998-05-26 2001-05-16 Schering Aktiengesellschaft Treatment of infertility with camp-increasing compounds alone or in combination with at least one meiosis-stimulating compound
CZ20012671A3 (cs) * 1999-02-26 2002-01-16 Novo Nordisk A/S Způsob in vitro oplodnění s pouľitím kultivačního média obsahujícího sterol aktivující meiosu
CA2382908A1 (en) 1999-09-16 2001-03-22 Novo Nordisk A/S Composition for ivf

Also Published As

Publication number Publication date
CA2382908A1 (en) 2001-03-22
HUP0202630A2 (hu) 2002-12-28
IL148234A0 (en) 2002-09-12
BR0014058A (pt) 2004-03-30
ATE306942T1 (de) 2005-11-15
NO323694B1 (no) 2007-06-25
KR20020032593A (ko) 2002-05-03
DE60023324T2 (de) 2006-07-20
UA78183C2 (en) 2007-03-15
EP1216059B1 (en) 2005-10-19
CZ2002591A3 (cs) 2002-08-14
WO2001019354A2 (en) 2001-03-22
DE60023324D1 (de) 2005-11-24
AU781994B2 (en) 2005-06-23
NO20021309L (no) 2002-03-15
US6844313B1 (en) 2005-01-18
ZA200201383B (en) 2002-11-27
MXPA02002439A (es) 2002-07-30
KR100757909B1 (ko) 2007-09-11
HUP0202630A3 (en) 2004-06-28
EP1216059A2 (en) 2002-06-26
JP2003509365A (ja) 2003-03-11
PL202224B1 (pl) 2009-06-30
ES2252048T3 (es) 2006-05-16
CN1222319C (zh) 2005-10-12
AU6985000A (en) 2001-04-17
WO2001019354A3 (en) 2001-06-14
RU2263516C2 (ru) 2005-11-10
NO20021309D0 (no) 2002-03-15
CN1373675A (zh) 2002-10-09

Similar Documents

Publication Publication Date Title
AU7779900A (en) Trifluoromethyl-substituted spirocyclic ketoenols
ID28965A (id) Azabisikloalkana sebagai modulator ccr5
AP2001002225A0 (en) 1-heterocycle substituted diarylamines.
ID29031A (id) Piperidin sebagai modulator ccr5
AU1482501A (en) Animal carrier
DK1093819T3 (da) Forbindelse og præparat til tilförsel af aktive midler
IL142525A0 (en) Novel membrane or matrix for controlling drug permeation
MX9800408A (es) Sales de derivados de amidina y de inhibidor de ciclooxigenasa, su procedimiento de preparacion, su aplicacion como medicamentos y composiciones farmaceuticas que los contienen.
TW200640505A (en) Device comprising VGF polypeptides
AU9534398A (en) Novel pharmaceutical composition
AU5892399A (en) 1, 2, 4-triazole-3-thione compounds
ZA200006463B (en) Composition for keeping away vermin.
AP2001002220A0 (en) Calcilytic compounds.
GB9907571D0 (en) Compounds
MY124078A (en) Eletriptan hydrobromide monohydrate
AU7978000A (en) Indium-enhanced bipolar transistor
GB9907001D0 (en) Gps for workstations
IL148234A0 (en) Composition for ivf
CA2268796A1 (fr) Composes bi-aromatiques relies par un radical heteroethynylene et compositions pharmaceutiques et cosmetiques les contenant
BR9713176A (pt) Benzotiofenos amorfos,métodos de preparação e métodos de uso
EP1278520A4 (en) DIARYL PIPERIDYL-PYRROLE DERIVATIVES AS AN ANTIPROTOZENE AGENT
AU2002331847A1 (en) Composition for stabilizing biological materials
HUP0202652A3 (en) Pharmaceutical carrier composition
AU7017300A (en) Biological device, especially for cell culture
CA2328832A1 (en) Processes for preparing pesticidal intermediates

Legal Events

Date Code Title Description
LAPS Decisions on the lapse of the protection rights

Effective date: 20090911